BioCentury
ARTICLE | Financial News

Akebia raises $58M in follow-on

July 7, 2017 8:22 PM UTC

On June 28, kidney disease company Akebia Therapeutics Inc. (NASDAQ:AKBA) raised $58 million through the sale of 4 million shares at $14.50 in a follow-on underwritten by Morgan Stanley, JMP Securiti...

BCIQ Company Profiles

Akebia Therapeutics Inc.